Expected earnings - Bioxytran Inc
Source: US Earnings Reports
Bioxytran Inc (BIXT) is expected to report for Q2 2025
Bioxytran Inc
NASDAQ: BIXT
BIXT Trading
10.93% G/L:
$0.0477 Last:
20,276 Volume:
$0.0423 Open:
BIXT Latest News
February 23, 2026 06:00:00 am
Bioxytran Initiates Research Collaboration with University of Georgia to Evaluate Drug Candidate's Ability to Block H5N1 Bird Flu Virus
February 17, 2026 07:00:00 am
Bioxytran, Inc. Announces Commercial Distribution Agreement with Khoury Medical LTD for A-SUQAR Dietary Supplement
February 11, 2026 06:00:00 am
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
BIXT Stock Data
$4,667,792
87,993,039
1.18%
1
N/A
Biotechnology & Life Sciences
Healthcare
US
Needham
